Clinical Trials Directory

Trials / Completed

CompletedNCT04023903

A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults

A Clinical Pharmacology Study of RTA 402 (Investigation of the Effect of Food on the Pharmacokinetics of RTA 402 Capsules in Japanese Healthy Adults and Comparison of the Pharmacokinetics With Those in Caucasian Healthy Adults)

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Kyowa Kirin Co., Ltd. · Industry
Sex
Male
Age
20 Years – 39 Years
Healthy volunteers
Accepted

Summary

Food effect part: To investigate the effect of food on the pharmacokinetics of RTA 402 and evaluate the safety of RTA 402 in Japanese healthy male adults, using the capsule formulations. Caucasian subject part: To investigate the pharmacokinetics of a single dose of RTA 402 administered in the fasted state and compare the pharmacokinetics with those observed in Japanese healthy male adults in the food effect part

Conditions

Interventions

TypeNameDescription
DRUGBardoxolone methylBardoxolone methyl 5 mg capsules
DRUGBardoxolone methylBardoxolone methyl 5 mg capsules

Timeline

Start date
2019-04-04
Primary completion
2019-06-14
Completion
2019-06-14
First posted
2019-07-18
Last updated
2020-02-05

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT04023903. Inclusion in this directory is not an endorsement.

A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults (NCT04023903) · Clinical Trials Directory